title: Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
authors.affiliation: Department of Radiation Oncology, Upstate Medical University, Syracuse, New York 13210, USA.
authors.forename: Stefania
authors.initials: S
authors.lastname: Morbidini-Gaffney
authors.forename: Tracy E
authors.initials: TE
authors.lastname: Alpert
authors.forename: Georges F
authors.initials: GF
authors.lastname: Hatoum
authors.forename: Robert H
authors.initials: RH
authors.lastname: Sagerman
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002280:Basal Cell Carcinoma / Q000209:etiology; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006044:Goiter, Nodular / Q000209:etiology; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy*; D006801:Humans; D008466:Mechlorethamine / Q000008:administration & dosage; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D016609:Neoplasms, Second Primary / Q000209:etiology*; D009442:Neurilemmoma / Q000209:etiology*; D010997:Pleural Neoplasms / Q000209:etiology*; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011878:Radiotherapy / Q000009:adverse effects*; D012008:Recurrence; D012878:Skin Neoplasms / Q000209:etiology; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D011241:Prednisone